deltatrials
Recruiting NA NCT04822077

Study on Proton Radiotherapy of Thymic Malignancies

PROTHYM - Phase II Non-randomized Study on Proton Radiotherapy Of Thymic Malignancies

Sponsor: Ass. Prof. Jan Nyman

Conditions Cardiotoxicity Pulmonary Toxicity Thymus Neoplasms
Interventions Proton radiation
Updated 3 times since 2021 Last updated: Mar 25, 2021 Started: Apr 18, 2018 Primary completion: Apr 1, 2026 Completion: Apr 1, 2029

This NA trial investigates Cardiotoxicity and Pulmonary Toxicity and is currently actively recruiting participants. Ass. Prof. Jan Nyman leads this study, which shows 3 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  3. Apr 2021 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ass. Prof. Jan Nyman
Data source: Swedish Lung Cancer Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Gothenburg, Sweden
  • • Stockholm, Sweden
  • • Umeå, Sweden